346 related articles for article (PubMed ID: 1403373)
1. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.
Kennedy JC; Pottier RH
J Photochem Photobiol B; 1992 Jul; 14(4):275-92. PubMed ID: 1403373
[TBL] [Abstract][Full Text] [Related]
2. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.
Kloek J; Akkermans W; Beijersbergen van Henegouwen GM
Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.
Kennedy JC; Pottier RH; Pross DC
J Photochem Photobiol B; 1990 Jun; 6(1-2):143-8. PubMed ID: 2121931
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.
Marcus SL; Sobel RS; Golub AL; Carroll RL; Lundahl S; Shulman DG
J Clin Laser Med Surg; 1996 Apr; 14(2):59-66. PubMed ID: 9484077
[TBL] [Abstract][Full Text] [Related]
5. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
6. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
7. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
8. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Peng Q; Warloe T; Berg K; Moan J; Kongshaug M; Giercksky KE; Nesland JM
Cancer; 1997 Jun; 79(12):2282-308. PubMed ID: 9191516
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results.
Kennedy JC; Marcus SL; Pottier RH
J Clin Laser Med Surg; 1996 Oct; 14(5):289-304. PubMed ID: 9612195
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder.
Leveckis J; Burn JL; Brown NJ; Reed MW
J Urol; 1994 Aug; 152(2 Pt 1):550-3. PubMed ID: 8015110
[TBL] [Abstract][Full Text] [Related]
12. On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation.
Collaud S; Juzeniene A; Moan J; Lange N
Curr Med Chem Anticancer Agents; 2004 May; 4(3):301-16. PubMed ID: 15134506
[TBL] [Abstract][Full Text] [Related]
13. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of protoporphyrin-IX in rat Leydig cells following induction by 5-aminolevulinic acid and tramadol.
Wołuń-Cholewa M; Butowska W; Warchoł W
Photomed Laser Surg; 2007 Dec; 25(6):526-9. PubMed ID: 18158756
[TBL] [Abstract][Full Text] [Related]
15. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
16. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA).
Rittenhouse-Diakun K; Van Leengoed H; Morgan J; Hryhorenko E; Paszkiewicz G; Whitaker JE; Oseroff AR
Photochem Photobiol; 1995 May; 61(5):523-8. PubMed ID: 7770514
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
18. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
[TBL] [Abstract][Full Text] [Related]
19. Glycoside esters of 5-aminolevulinic acid for photodynamic therapy of cancer.
Vallinayagam R; Schmitt F; Barge J; Wagnieres G; Wenger V; Neier R; Juillerat-Jeanneret L
Bioconjug Chem; 2008 Apr; 19(4):821-39. PubMed ID: 18341270
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid.
de Blois AW; Thissen MR; de Bruijn HS; Grouls RJ; Dutrieux RP; Robinson DJ; Neumann HA
J Photochem Photobiol B; 2001 Aug; 61(1-2):21-9. PubMed ID: 11485844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
